We are live on ! Find out more
BCA

Benchmark Capital Advisors Portfolio holdings

AUM $101M
1-Year Est. Return 0.8%
This Fund
S&P 500
This Quarter Est. Return
+9.68%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$139M
AUM Growth
+$9.62M
Cap. Flow
+$2.42M
Cap. Flow %
1.74%
Top 10 Hldgs %
27.84%
Holding
157
New
14
Increased
39
Reduced
52
Closed
19

Top Buys

Rank Stock Value
1
VOD icon
Vodafone
VOD
+$2.49M
2
BMY icon
Bristol-Myers Squibb
BMY
+$2.34M
3
GM
GEN MOTORS CORP
GM
+$2.05M
4
PCYC
PHARMACYCLICS INC
PCYC
+$1.37M
5
META icon
Meta Platforms (Facebook)
META
+$1.07M

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$1.98M
2
HHH icon
Howard Hughes
HHH
+$1.7M
3
DNY
DONNELLEY R R & SONS CO
DNY
+$1.39M
4
NEM icon
Newmont
NEM
+$860K
5
GLW icon
Corning
GLW
+$834K

Sector Composition

Rank Sector Weight
1 Miscellaneous 20.67%
2 Energy 14.21%
3 Technology 10.78%
4 Healthcare 9.81%
5 Consumer Discretionary 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVG
101
DELISTED
AVG Technologies N.V.
AVG
$215K 0.15%
9,000
-16,000
-64% -$356K
BSJF
102
DELISTED
GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF
BSJF
$214K 0.15%
8,000
– –
IBM icon
103
IBM
IBM
$225B
$207K 0.15%
1,172
-1,098
-48% -$200K
FAX
104
abrdn Asia-Pacific Income Fund
FAX
$602M
$174K 0.12%
4,783
-167
-3% -$6.11K
PWE
105
DELISTED
Penn West Energy Petroleum Ltd
PWE
$144K 0.1%
13,015
-7,630
-37% -$88.5K
PCM
106
PCM Fund
PCM
$66.7M
$142K 0.1%
12,400
– –
CCEC
107
Capital Clean Energy Carriers
CCEC
$1.37B
$136K 0.1%
2,151
-5,300
-71% -$343K
RMBS icon
108
Rambus
RMBS
$9.88B
$117K 0.08%
12,500
-7,500
-38% -$68.7K
DENN
109
DELISTED
Denny's
DENN
$113K 0.08%
18,500
-20,000
-52% -$117K
PDL.B
110
DELISTED
PRESIDENTAL RLTY CL B
PDL.B
$91K 0.07%
302,922
– –
ARTX
111
DELISTED
Arotech Corporation
ARTX
$87K 0.06%
+50,000
New +$85.5K
RDI icon
112
Reading International Class A
RDI
$48.1M
$78K 0.06%
11,900
– –
DARA
113
DELISTED
DARA BIOSCIENCES INC COM STK (DE)
DARA
$64K 0.05%
26,100
– –
ATNY
114
DELISTED
API TECHNOLOGIES CORP. COMMON STOCK
ATNY
$57K 0.04%
+19,500
New +$56.6K
GLW icon
115
Corning
GLW
$132B
– –
-58,600
Closed -$834K
IYY icon
116
iShares Dow Jones US ETF
IYY
$3.06B
– –
-11,400
Closed -$460K
LGND icon
117
Ligand Pharmaceuticals
LGND
$5.67B
– –
-84,799
Closed -$1.98M
NEM icon
118
Newmont
NEM
$139B
– –
-28,700
Closed -$860K
RTX icon
119
RTX Corp
RTX
$286B
– –
-8,739
Closed -$511K
TNK icon
120
Teekay Tankers
TNK
$3.06B
– –
-1,438
Closed -$30K
TWO
121
DELISTED
Two Harbors Investment
TWO
– –
-1,875
Closed -$154K
UVXY icon
122
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$272M
– –
0
– -$394K
VC icon
123
Visteon
VC
$2.7B
– –
-4,500
Closed -$284K
XLV icon
124
State Street Health Care Select Sector SPDR ETF
XLV
$44.6B
– –
-6,800
Closed -$324K
GAP
125
The Gap Inc
GAP
$7.48B
– –
-8,700
Closed -$363K
2 3 4
5
6

Similar funds

OIMU
Orbis Investment Management (US) San Francisco, California $99.7M AUM 17.51% 1-Year Est. Return
7A
734 Agriculture New York $93.8M AUM 0% 1-Year Est. Return
JCP
Jabre Capital Partners Geneva, Switzerland $87.8M AUM 5.24% 1-Year Est. Return
DCM
Diag Capital Management New York $87.4M AUM
BCEM
Bayou City Energy Management Houston, Texas $85.4M AUM
QAM
Questar Asset Management Minneapolis, Minnesota $85M AUM
CFA
Clarfeld Financial Advisors Tarrytown, New York $120M AUM
BPV
Battery Partners VIII Boston, Massachusetts $121M AUM 101.35% 1-Year Est. Return

Benchmark Capital Advisors's Q3 2013 Portfolio in Review

As of Q3 2013, Benchmark Capital Advisors held 157 positions worth $139M, up 7.4% from $130M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Benchmark Capital Advisors's Q3 2013 filing shows 14 new, 39 increased, 52 reduced and 19 closed positions. Its largest new stake was Bristol-Myers Squibb: 53,400 shares worth $2.47M. The largest sale was Ligand Pharmaceuticals, an estimated $1.98M.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 24% a quarter earlier, followed by Energy and Technology.

  • Benchmark Capital Advisors's largest Q3 2013 buy was Bristol-Myers Squibb: 53,400 shares worth $2.47M.
  • Benchmark Capital Advisors added most to Vodafone in Q3 2013, an estimated $2.49M increase.
  • Benchmark Capital Advisors's biggest Q3 2013 reduction was Howard Hughes, cutting an estimated $1.7M.
  • Benchmark Capital Advisors fully exited Ligand Pharmaceuticals in Q3 2013, selling an estimated $1.98M.
  • Benchmark Capital Advisors's ten largest holdings make up 28% of its $139M portfolio in Q3 2013.
  • Benchmark Capital Advisors opened 14 new positions and closed 19 in Q3 2013.
  • Benchmark Capital Advisors's portfolio value rose 7.4% quarter-over-quarter to $139M.

Based on Benchmark Capital Advisors's 13F filing for Q3 2013, filed 23 Oct 2013.